Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike Niessner

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Cancer|May 26, 2017
Molecular insights into melanoma brain metastasesDana Westphal, Isabella C Glitza Oliva, Heike Niessner
Wiener Medizinische Wochenschrift (1946)|June 13, 2015
Molecular mechanisms of pharmacological doses of ascorbate on cancer cellsSascha Venturelli, Tobias W Sinnberg, Heike Niessner, et al.
Cellular Immunology|February 27, 2018
Inhibiting HSP90 prevents the induction of myeloid-derived suppressor cells by melanoma cellsNicole Janssen, Lisa Speigl, Graham Pawelec, et al.
Cancers|December 2, 2020
Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma-Old Myth or New Logos?Francisco Meraz-Torres, Sarah Plöger, Claus Garbe, et al.
International Journal of Molecular Sciences|October 16, 2025
Combinatorial ERK Inhibition Enhances MAPK Pathway Suppression in BRAF-Mutant MelanomaCorinna Kosnopfel, Tobias Sinnberg, Shrunal Mane, et al.
Biology Open|May 3, 2018
Embryonic bone morphogenetic protein and nodal induce invasion in melanocytes and melanoma cellsTobias Sinnberg, Heike Niessner, Mitchell P Levesque, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2017
The mitogen-activated protein kinase pathway in melanoma part I - Activation and primary resistance mechanisms to BRAF inhibitionTeresa Amaral, Tobias Sinnberg, Friedegund Meier, et al.
European Journal of Cancer (Oxford, England : 1990)|February 7, 2017
MAPK pathway in melanoma part II-secondary and adaptive resistance mechanisms to BRAF inhibitionTeresa Amaral, Tobias Sinnberg, Friedegund Meier, et al.
Antioxidants (Basel, Switzerland)|April 28, 2023
Relevant Membrane Transport Proteins as Possible Gatekeepers for Effective Pharmacological Ascorbate Treatment in CancerChristian Leischner, Luigi Marongiu, Alban Piotrowsky, et al.
Cancers|November 13, 2021
Individualized Proteogenomics Reveals the Mutational Landscape of Melanoma Patients in Response to ImmunotherapyMarisa Schmitt, Tobias Sinnberg, Heike Niessner, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Cancer|May 26, 2017
Molecular insights into melanoma brain metastasesDana Westphal, Isabella C Glitza Oliva, Heike Niessner
Wiener Medizinische Wochenschrift (1946)|June 13, 2015
Molecular mechanisms of pharmacological doses of ascorbate on cancer cellsSascha Venturelli, Tobias W Sinnberg, Heike Niessner, et al.
Cellular Immunology|February 27, 2018
Inhibiting HSP90 prevents the induction of myeloid-derived suppressor cells by melanoma cellsNicole Janssen, Lisa Speigl, Graham Pawelec, et al.
Cancers|December 2, 2020
Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma-Old Myth or New Logos?Francisco Meraz-Torres, Sarah Plöger, Claus Garbe, et al.
International Journal of Molecular Sciences|October 16, 2025
Combinatorial ERK Inhibition Enhances MAPK Pathway Suppression in BRAF-Mutant MelanomaCorinna Kosnopfel, Tobias Sinnberg, Shrunal Mane, et al.
Biology Open|May 3, 2018
Embryonic bone morphogenetic protein and nodal induce invasion in melanocytes and melanoma cellsTobias Sinnberg, Heike Niessner, Mitchell P Levesque, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2017
The mitogen-activated protein kinase pathway in melanoma part I - Activation and primary resistance mechanisms to BRAF inhibitionTeresa Amaral, Tobias Sinnberg, Friedegund Meier, et al.
European Journal of Cancer (Oxford, England : 1990)|February 7, 2017
MAPK pathway in melanoma part II-secondary and adaptive resistance mechanisms to BRAF inhibitionTeresa Amaral, Tobias Sinnberg, Friedegund Meier, et al.
Antioxidants (Basel, Switzerland)|April 28, 2023
Relevant Membrane Transport Proteins as Possible Gatekeepers for Effective Pharmacological Ascorbate Treatment in CancerChristian Leischner, Luigi Marongiu, Alban Piotrowsky, et al.
Cancers|November 13, 2021
Individualized Proteogenomics Reveals the Mutational Landscape of Melanoma Patients in Response to ImmunotherapyMarisa Schmitt, Tobias Sinnberg, Heike Niessner, et al.
Pageof 6